Sterilization Monitoring Market (2025 - 2033)

Sterilization Monitoring Market Summary

The global sterilization monitoring market size was estimated at USD 962.8 million in 2024 and is projected to reach USD 1,843.2 million by 2033, growing at a CAGR of 7.57% from 2025 to 2033. The market is experiencing significant growth driven by various factors. Increasing cases of Healthcare-Associated Infections (HAIs) worldwide and a growing number of inpatient surgeries are a primary catalyst.

Increasing prevalence of healthcare-associated infections (HAIs) is projected to significantly contribute to the growth of the sterilization monitoring market. Hospitals and clinics are under continuous pressure to improve sterilization standards to prevent infections caused by inadequately sterilized equipment. For instance, according to data released by the European Centre for Disease Prevention and Control, a European Union Agency, in May 2024, approximately 4.3 million hospitalized patients across the EU and European Economic Area (EEA) are affected by HAIs annually. These infections pose serious health risks and also place a significant strain on healthcare systems.

Another significant factor is the stringent regulatory environment. Governments and health authorities worldwide mandate strict sterilization standards, compelling healthcare institutions to adopt effective monitoring systems. For instance, in November 2024, the FDA issued a guidance “Transitional Enforcement Policy for Ethylene Oxide Sterilization Facility Changes for Class III Devices”.This guidance outlines a policy of transitional enforcement discretion for manufacturers of specific Class III devices. It aims to address expected changes in ethylene oxide (EtO) sterilization processes and to help prevent or reduce the risk of medical device supply chain disruptions or shortages during the period when sterilization facilities are transitioning to meet new Environmental Protection Agency (EPA) regulations.

Another major factor driving the sterilization monitoring industry growth is growing surgical procedures in hospitals. For instance, according to the Eurostat report, the two most common surgical operations and procedures performed in EU hospitals are cataract surgery and caesarean sections.

Surgical Operations and Procedures Performed in Hospitals - Top 10 Procedures, Group 1, 2022

Source: Eurostat

Surgical Operations and Procedures Performed in Hospitals - Top 10 Procedures, Group 2, 2022

Source: Eurostat

Number of Hospitals and Admissions, U.S.

Source: American Hospital Association

Furthermore, the rising adoption of minimally invasive surgeries and complex medical devices necessitates more reliable sterilization methods. As procedures become more sophisticated, so does the need for precise sterilization monitoring to ensure safety and efficacy, propelling market expansion.

Innovation in sterilization monitoring primarily revolves around the development of faster, more reliable, and integrated solutions. Traditional methods such as biological indicators (BIs) and chemical indicators have been supplemented or replaced by advanced technologies offering real-time or near-real-time results.

For example, chemical indicators like ASP’s SEALSURE Chemical Indicator Tape provide immediate visual confirmation of sterilization cycles, simplifying process validation. Biological indicators such as STERRAD VELOCITY Biological Indicator now integrate with digital readers to streamline result interpretation and record-keeping, reducing human error and saving time.

Digital innovations include the integration of sterilization monitoring devices with hospital information systems, enabling automated data capture and traceability. This connectivity enhances compliance, simplifies audits, and facilitates trend analysis over time. Moreover, the development of multi-modal indicators that can monitor multiple sterilization parameters simultaneously is gaining traction, providing comprehensive assurance in a single test.

Major Brands Operating in the Market

Source: Company Websites

Key Opinion Leaders' Responses

Market Concentration & Characteristics

The sterilization monitoring industry exhibits a moderate to high degree of innovation driven by technological advancements. Innovations include the development of real-time biological and chemical indicators. Companies are investing in advanced data analytics and cloud-based platforms to enhance accuracy and compliance. Additionally, environmentally friendly sterilization methods and miniaturized, portable indicators are gaining traction. For instance, Hu-Friedy’s IMS Monitor Tape is environmentally friendly and excludes the risk of lead contamination and improves safety for patients and users with latex allergies. In addition, most of the chemical indicators are often small and portable, making them easy to use in different settings.

Regulation significantly influences the market for sterilization monitoring by ensuring safety, efficacy, and quality standards. Stricter regulations drive innovation, prompting companies to develop advanced monitoring technologies, such as biological indicators and electronic systems. Compliance increases trust among healthcare providers and patients, reducing the risk of infections and sterilization failures. Conversely, overly stringent policies may raise costs and limit market entry for smaller players.

The sterilization monitoring market has experienced a low but strategic level of mergers and acquisitions (M&A), reflecting the industry's drive for innovation, expanded capabilities, and market consolidation.

Technology substitutes for sterilization monitoring are limited, as there are currently no direct alternatives or substitutes available for sterilization monitoring products in the market. There is physical/mechanical monitoring; however, it does not replace the indicators.

Market concentration remains significant, with key players dominating the sterilization monitoring industry. Major companies such as 3M, Getinge, ASP, STERIS, and GKE (Mesa Labs, Inc.) hold substantial market shares due to their extensive Technology portfolios, technological advancements, and strong distribution networks. This high level of concentration indicates limited competition and potential barriers for new entrants.

Technology Insights

The biological indicators segment held the largest revenue share of 58.12% in 2024 and is also expected to register the fastest CAGR of 7.95% during the forecast period. In 2024, biological indicators remain the dominant segment in the sterilization monitoring market, primarily due to their unmatched accuracy and regulatory acceptance across various sterilization methods such as steam sterilization, ethylene oxide (EO), and hydrogen peroxide (H₂O₂) sterilization. Biological indicators (BIs) are considered the gold standard for verifying sterilization effectiveness because they directly assess the sterilization process's ability to eliminate microbial life, ensuring patient safety and compliance with stringent healthcare standards.

Steam sterilization, widely used in hospitals and surgical centers, relies heavily on biological indicators because of its proven reliability in confirming sterilization cycles. Similarly, ethylene oxide sterilization, often employed for heat-sensitive instruments, requires rigorous validation, which BIs provide. Hydrogen peroxide sterilization, a newer but rapidly expanding method, also benefits from biological indicators to ensure sterilant penetration and microbial kill efficacy.

Several key factors drive the dominance of biological indicators. First, regulatory agencies such as the FDA and CDC mandate the use of biological indicators for sterilization validation, especially in critical healthcare settings, making them indispensable for compliance. Second, biological indicators offer high sensitivity and accuracy, providing definitive proof of sterilization success, which is crucial for patient safety and infection control. Third, technological advancements have led to the development of rapid BIs, reducing turnaround times and increasing their practicality in busy healthcare environments.

The chemical indicators segment is anticipated to experience significant growth in the global sterilization monitoring industry due to several key factors, such as increasing regulatory requirements and standards across healthcare and pharmaceutical industries, emphasizing the importance of real-time process verification, which chemical indicators provide. These indicators deliver immediate feedback on sterilization parameters such as temperature, pressure, and exposure time, allowing facilities to quickly identify potential process deviations and take corrective actions.

Advancements in chemical indicator technology have led to the development of more sophisticated, reliable, and easy-to-use products. According to the CDC, there are primarily six classes of chemical indicators. The CDC recommends using at least two types: an external (Type 1) indicator and an internal indicator (Types 3, 4, 5, or 6), placed both inside and outside each instrument package. It is important to understand that this classification does not imply a hierarchy; for example, Type 6 is not superior to Type 1-each simply assesses different parameters. The choice of indicator depends on the specific measurement requirements for the sterilization process.

Integration of chemical indicators with digital systems and automation enhances process control and documentation, which is highly valued in modern sterilization workflows.

Product Insights

The strips segment held the largest revenue share in 2024 and is also expected to register the fastest growth over the forecast period. The strips segment continues to dominate the sterilization monitoring market due to its cost-effectiveness, ease of use, and rapid results. Sterilization indicator strips are widely preferred in healthcare settings, especially in low- to mid-volume facilities, because they provide a simple and reliable method for quick verification of sterilization cycles without requiring complex equipment or extensive training. Their ability to deliver immediate visual confirmation of sterilization parameters such as temperature and exposure makes them highly practical for routine monitoring and quality assurance. Additionally, the affordability of strips allows for widespread adoption across various healthcare institutions, contributing to their dominant market share.

The indicator tapes segment is anticipated to experience significant growth within the sterilization monitoring industry, due to several compelling factors. Their widespread use in healthcare facilities, especially for packaging and tracking sterilization cycles, makes them an indispensable and cost-effective solution for quick validation. Advancements in indicator tape technology, such as improved visibility, enhanced sensitivity, and integration of chemical indicators that provide more reliable and immediate results, are driving their popularity.

Additionally, regulatory bodies increasingly emphasize the importance of efficient sterilization verification, prompting healthcare providers to adopt more accessible and straightforward monitoring tools like indicator tapes. Furthermore, ASP’s STERRAD VELOCITY Biological Indicator (BI) and Process Challenge Device (PCD) is the first and only all-in-one solution designed for hydrogen peroxide sterilization systems, meeting AAMI ST582 recommended practices to ensure optimal protection for every patient and every cycle. This indicates a growing trend toward increased adoption of sterilization monitoring systems in the coming years, driven by innovations and market entry.

Method Insights

The steam sterilization segment held the largest share of the sterilization monitoring market in 2024. Steam sterilization is considered the gold standard for sterilizing a broad range of instruments and equipment because of its proven efficacy, cost-effectiveness, and reliability. The high prevalence of steam sterilization processes in hospitals and clinics drives the demand for advanced monitoring solutions tailored specifically for this method. Key driving factors include stringent regulatory standards that mandate rigorous sterilization validation, the increasing complexity of medical devices requiring precise sterilization verification, and technological advancements in sterilization monitoring systems that ensure accurate, real-time validation of steam sterilization cycles. Moreover, the growing focus on patient safety and infection control further fuels the adoption of sophisticated monitoring tools for steam sterilization, maintaining its dominant position in the market in 2024.

The hydrogen peroxide sterilization segment is anticipated to witness the fastest CAGR over the forecast period, due to several compelling factors. The increasing adoption of low-temperature sterilization processes, especially in hospitals and medical device manufacturing, has significantly boosted demand for hydrogen peroxide-based sterilization monitoring products. The growing emphasis on patient safety, coupled with the need for reliable, safe, and eco-friendly sterilization methods, is propelling the hydrogen peroxide segment's rapid growth in 2024, positioning it as a preferred choice in modern sterilization practices.

End Use Insights

The hospitals and clinics segment held the largest revenue share of the sterilization monitoring industry in 2024. Hospitals and clinics perform a large number of surgeries and procedures requiring sterilized instruments daily, driving the demand for reliable sterilization monitoring solutions. Furthermore, several hospitals are investing in advanced sterilization and monitoring technologies to ensure patient safety and comply with quality standards.

The ambulatory surgery centers segment is anticipated to experience the fastest CAGR over the forecast period, driven by increasing preference for outpatient procedures and expansion of ambulatory surgery center facilities, among others. For instance, according to UPMC HealthBeat, a publishing website for UPMC, an integrated health care system based in Pittsburgh, reports that many procedures and surgeries are now routinely performed on an outpatient basis. Common outpatient procedures and types of outpatient surgeries include:

• Cataract surgery: Removing the cloudy natural lens of the eye and replacing it with an artificial lens.

• Ear, nose, and throat (ENT) surgeries: Such as tonsil and adenoid removal.

• Cosmetic surgeries: Including breast reconstruction and skin grafts.

• Urologic procedures: Such as vasectomy.

• Orthopedic procedures: Including knee and hip replacements, as well as surgeries on toes, feet, ankles, and legs.

• Gallbladder removal.

• Skin procedures: Such as mole removal and other skin repairs.

• Lumpectomy: Removal of a cancerous tumor in the breast.

• Colonoscopy and endoscopy.

• Hand, wrist, elbow, and ankle surgeries: Including procedures for arthritis.

• Tendon and muscle repairs: Such as rotator cuff surgery.

• Gynecological procedures: Including dilation and curettage (D&C) and tubal ligation.

• Hemodialysis: For patients with kidney disease.

• Hernia repairs.

• Hemorrhoid procedures.

• Kidney stone treatment

Additionally, the same report indicates that approximately two-thirds of all surgical procedures are now performed in outpatient settings. As the number of surgeries conducted in outpatient environments continues to increase, this trend is expected to further drive the demand for sterilization monitoring products in ambulatory surgery centers.

Regional Insights

North America sterilization monitoring market accounted for the largest revenue share of 35.49% in 2024, driven by the increasing demand for infection control and patient safety in healthcare settings. The region’s well-established healthcare infrastructure, stringent regulatory standards, and technological advancements contribute to the growth of sterilization monitoring products and services. Hospitals, clinics, pharmaceutical companies, and medical device manufacturers in North America prioritize sterilization validation and monitoring to prevent healthcare-associated infections (HAIs) and ensure compliance with agencies like the FDA and CDC.

The rising prevalence of chronic diseases, surgical procedures, and the need for sterilized medical equipment further boost market demand. Additionally, the adoption of innovative sterilization technologies, such as biological and chemical indicators, automated monitoring systems, and real-time data management tools, is increasing in the region, thereby contributing to market growth. The North American market is characterized by the presence of key players focusing on Technology innovation, strategic partnerships, and regulatory compliance to strengthen their market position.

Furthermore, the region’s focus on healthcare quality standards and infection prevention policies supports market expansion. However, high costs associated with sterilization monitoring equipment and stringent regulatory procedures may pose challenges. Overall, North America remains a dominant market for sterilization monitoring, with steady growth prospects in the coming years.

U.S. Sterilization Monitoring Market Trends

The U.S. held the largest share of 67.84% in 2024 in the North America sterilization monitoring industry. The widespread adoption of both traditional and advanced sterilization monitoring methods, including biological and chemical indicators, characterizes the market. Biological indicators are considered the gold standard for verifying sterilization efficacy, while chemical indicators provide immediate process validation, and physical monitors track parameters like temperature, pressure, and time.

The U.S. market benefits from stringent regulatory frameworks established by agencies such as the FDA and CDC, which mandate rigorous sterilization procedures to prevent healthcare-associated infections (HAIs). Additionally, the rise of outpatient surgeries and increasing healthcare infrastructure investments contribute to the expanding demand.

Europe Sterilization Monitoring Market Trends

Growth of Europe’s sterilization monitoring industry is primarily driven by the region’s stringent regulatory standards and increasing healthcare infrastructure. The demand for effective sterilization processes is growing due to the rising prevalence of hospitals, clinics, and surgical centers, alongside a heightened focus on infection control and patient safety. European countries such as Germany, France, the UK, and Italy are key markets, supported by robust healthcare systems and government initiatives promoting medical safety. Technological advancements, including the adoption of automated and real-time monitoring systems, are transforming the market by enhancing accuracy, efficiency, and compliance with regulatory standards like the EU Medical Device Regulation (MDR). Companies operating in Europe are investing heavily in R&D to develop innovative sterilization monitoring solutions, such as biological indicators, chemical indicators, and digital monitoring devices.

The sterilization monitoring market in the UK is experiencing steady growth driven by increasing healthcare infrastructure, rising awareness of infection control, and stringent regulatory standards. The demand for effective sterilization processes in hospitals, clinics, pharmaceuticals, and biotechnology sectors is fueling the adoption of advanced sterilization monitoring systems. The UK government's emphasis on patient safety and infection prevention has led healthcare providers to invest in reliable monitoring solutions to ensure compliance with regulatory guidelines such as those from the MHRA and NHS standards.

Key players in the UK sterilization monitoring industry offer a range of products including biological, chemical, and physical indicators for sterilization validation. Innovations in real-time monitoring and automation are enhancing operational efficiency and ensuring higher safety standards. The market also benefits from increasing adoption of sterilization monitoring in pharmaceutical manufacturing and research laboratories. Overall, the UK market is poised for continued growth, driven by technological advancements, regulatory compliance needs, and an increasing focus on infection control in healthcare settings.

Asia Pacific Sterilization Monitoring Market Trends

The sterilization monitoring industry in Asia Pacific is witnessing a rapid growth driven by rising prevalence of surgical procedures and expanding pharmaceutical and biotech industries. Countries such as China, India, Japan, South Korea, and Southeast Asian nations are key contributors to this expansion. The growing awareness of infection control and sterilization protocols in hospitals, clinics, and laboratories has further fueled demand for advanced sterilization monitoring solutions.

The sterilization monitoring market in China is experiencing rapid growth driven by expanding healthcare infrastructure, technological advancements, and increasing regulatory standards. As one of the largest healthcare markets globally, China’s rising investments in hospitals, clinics, and pharmaceutical manufacturing facilities have heightened the demand for effective sterilization solutions. The government’s focus on improving healthcare quality and safety standards has led to stringent sterilization practices, further fueling the adoption of advanced monitoring systems.

The key market players are introducing innovative products such as biological indicators, chemical indicators, and automated monitoring systems tailored to meet local needs. The growing awareness of infection control and the need for compliance with international standards like ISO and WHO regulations also contribute to market expansion.

Latin America Sterilization Monitoring Market Trends

The Latin America sterilization monitoring industry is influenced by several key driving factors. Firstly, increasing healthcare infrastructure development across countries such as Brazil, Mexico, and Argentina is fueling demand for advanced sterilization technologies to ensure patient safety. As healthcare facilities expand and modernize, there is a growing need for reliable sterilization processes to prevent infections and improve overall healthcare outcomes. Secondly, the rising prevalence of HAIs has prompted healthcare providers to adopt stringent sterilization protocols, further boosting market growth.

Middle East and Africa Sterilization Monitoring Market Trends

The Middle East and Africa sterilization monitoring industry is experiencing significant growth driven by rising awareness of infection control and increasing demand for sterilization processes across medical facilities. Factors fueling market growth include the rising prevalence of infectious diseases, government initiatives to improve healthcare quality, and increasing investments in healthcare modernization. Additionally, the growing number of medical device manufacturers and the expansion of healthcare services in emerging economies like South Africa, Saudi Arabia, and the UAE further propel the demand for sterilization monitoring products.

Key Sterilization Monitoring Company Insights

The sterilization monitoring market is moderately fragmented, with both major and local market competitors. Due to the fact that the current market players are stepping up their efforts to grab the majority market share, fierce competition is anticipated, with the degree of competitiveness perhaps rising even higher. Many market participants are engaging in various strategic activities, such as product launches, mergers and acquisitions, and geographic growth, in an effort to gain a competitive edge over rivals. Thus, the market is predicted to witness growth during the forecast period.

Recent Developments

• In June 2025, Solventum, one of the global leaders in MedTech innovation focused on infection prevention, announced the launch of its Attest Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack. This ready-to-use test combines two FDA-cleared indicators- a biological indicator (BI) that confirms microbial neutralization and a chemical indicator (CI) that verifies proper sterilizer performance- into a single-use pack featuring a transparent container.

• In March 2024, the U.S. Environmental Protection Agency (EPA) announced the final amendments to the National Emission Standards for Hazardous Air Pollutants (NESHAP) concerning Ethylene Oxide (EtO) Commercial Sterilizers. Since 2019, the EPA has been collecting information on ways to lower public exposure risks to EtO. This new rule is one of the EPA’s key efforts to reduce EtO emissions while also addressing potential supply chain impacts. The standards finalized under the Clean Air Act aim to decrease the lifetime cancer risk from EtO emissions associated with commercial sterilizers to or below the benchmark of 100 cases per million people exposed. Additionally, they are expected to cut the number of individuals with a risk of one in one million or higher by approximately 92 percent.

• In October 2023, ASP announced a significant expansion of its Sterilization Monitoring (SM) portfolio with new Steam Monitoring products. These innovations are designed to help Sterile Processing Departments (SPDs) enhance sterilization assurance with greater efficiency and confidence in results. ASP’s expanded SM portfolio aims to improve workflow through integrated solutions within Sterile Processing Departments and Central Sterilization Supply Departments (CSSDs). The portfolio offers comprehensive sterility assurance across all major sterilization modalities and includes:

• BIOTRACE Readers: Facilitate faster result readings and support compliance through enhanced workflow and connectivity.

• BIOTRACE Biological Indicator: Provides a streamlined, integrated workflow with a new SM traceability solution for efficient monitoring of steam sterilization processes.

• VERISURE Chemical Indicator: Enables rapid and straightforward monitoring of sterilization cycles.

• SEALSURE Steam Indicator Tape: Visual indicator tape to easily differentiate processed from unprocessed steam items.

Sterilization Monitoring Market